Search

Headquarters

Contact Us

  • (+01) 512 835 8026
  • 3300 Duval Road
    Austin, TX 78759
    USA
  • Mon to Fri - 8:50am to 5:00pm

Ready to order?

Great! Every order starts with a quote.

Get Started 

  • (+01) 512 835 8026
  • Email Us
Get a Quote Contact | FAQ's | Blog
Rules-Based Medicine Rules-Based Medicine

a Q<sup>2</sup> Solutions Company

Toggle menu

Skip to content
  • About Us

    • About RBM

      Rules-Based Medicine (RBM), a Q2 Solutions Company, is a CLIA certified, multiplexed immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services.

    • About RBM

      • About Us
      • Our Scientists
      • Quality Policy
      • Employment
      • Partners
      • Sales Team
      • Certifications

    • Newsroom

      • Press
      • Company Newsletters
      • Conferences
      • Abstracts + Papers
      • Sign Up for Our Newsletter
      • Blog

    • Data Quality

      • Overview
      • RBM Technology
  • Biomarker Solutions

    • Solutions

      • Overview
      • Assay Change Log

      CustomMAP

      If a smaller, more focused panel of analytes is required, we can build a Custom MAP to meet your needs.

      Learn More »

      TruCulture Spike

    • Multiplexed Immunoassays

      • NEW! Idiopathic Pulmonary Fibrosis (IPF) Biomarkers
      • Full Biomarker Menu
      • DiscoveryMAP® v. 4.0
      • ExplorerMAP™ v. 1.0
      • HumanMAP® v. 2.0
      • CardiovascularMAP® v. 3.0
      • AngiogenesisMAP® v. 1.0
      • InflammationMAP® v. 1.1
      • ImmunoMAP® v. 1.0
      • MetabolicMAP® v. 1.0
      • KidneyMAP®
      • CytokineMAP A
      • CytokineMAP B
      • SARS-CoV-2/COVID-19 Research
      • Cytokine Storm Testing for SARS-CoV-2/COVID-19 Research
    • TruCulture

      Whole Blood Collection and Culture System

      Learn More »
      Quanterix simoa

      Ultrasensitive immunoassays manufactured by RBM and based on Quanterix’s Simoa technology.

      Learn More »
  • Resources + Support

    • Resources

      • Bibliography
      • White Papers
      • Application Notes
      • Events
      • Webinars
      • Blog
      • COVID-19/SARS-CoV-2 Research Tools

    • Support

      • Client Services
      • Request a Biomarker
      • Speak to a Scientist
  • How to Order

    • Ordering Information

      • How to Order
      • Request a quote
      • Acceptable Samples
      • Frequently Asked Questions

    • Request Information

      • Contact Client Services
      • Request a Biomarker
      • Speak to a Scientist

    • Ready to Order?

      Great!

      Every order starts with a quote.

      Get Started

Category Archives: Blog

20 Oct 2020

TruCulture is Shown to Standardize Immune Monitoring, Again

October 20, 2020
Rules-Based Medicine
Blog, TruCulture
...
Read More
5 Oct 2020
luminex multiplexing machines for biomarker testing

Blood Test Developed for Kawasaki Disease

October 5, 2020
Rules-Based Medicine
Blog, Utilized Rules-Based Medicine's Services
...
Read More
27 Aug 2020

IFN-α, IFN-β, & IFN-λ Ultrasensitive Immunoassay Applications for Viral Pneumonia Including COVID-19

August 27, 2020
Rules-Based Medicine
Blog, COVID-19
...
Read More
28 Jul 2020
Myriad RBM, TruCulture, Immunomonitoring logo

Occupational Exposure to Carbon Nanotubes/Fibers & Immune Response using TruCulture

July 28, 2020
Rules-Based Medicine
Blog, TruCulture, Utilized Rules-Based Medicine's Services
...
Read More
26 May 2020

Cerecor and Myriad Genetics Announce that Levels of Novel Cytokine, LIGHT Were Highly Correlated with Disease Severity and Mortality in COVID-19 ARDS Biomarker Study – Press Release

May 26, 2020
Rules-Based Medicine
Blog, Press
...
Read More
22 May 2020

Bibliography Updates May 2020

May 22, 2020
Rules-Based Medicine
Autoimmune and Arthritis, Blog, Cancer, Neuroscience and Neurological, Utilized Rules-Based Medicine's Services
Rules-Based Medicine's, a Q2 Solutions Company (formerly Myriad RBM) biomarker testing services and TruCulture product have been cited in over 1000 pe...
Read More
10 Mar 2020
IPF

Prognostic Lung Fibrosis Consortium (PROLIFIC) /Myriad RBM Collaborate on Pulmonary Fibrosis Biomarker Panel

March 10, 2020
Rules-Based Medicine
Blog
PROLIFIC - Idiopathic Pulmonary Fibrosis Celgene, a wholly owned subsidiary of Bristol-Myers Squibb Company, created a consortium called PROLIFIC (Pr...
Read More
1 2 3 … 20

Categories

  • Biomarkers (4)
  • Blog (134)
    • Autoimmune and Arthritis (10)
    • Cancer (28)
    • Cardiac (9)
    • Cytokines and Chemokines (20)
    • Diabetes (7)
    • Gastrointestinal (1)
    • Inflammation (42)
    • Neuroscience and Neurological (33)
    • News From the Lab (1)
    • Renal Function and Toxicity (8)
    • Technology- Multi-Analyte Profile (1)
    • TruCulture (2)
  • COVID-19 (1)
  • Press (37)
  • Utilized Rules-Based Medicine's Services (43)

ABOUT RBM

Overview
Our Scientists
Quality Policy
Employment
Partners
Sales Team
Certifications

A Q2 Solutions Company

Contact Us

Q2 Solutions, a wholly owned subsidiary and laboratory division of IQVIA, is a leading global clinical trial laboratory services organization providing comprehensive testing, project management, supply chain, biorepository and specimen management, and clinical trial sample and consent tracking solutions. Learn more at www.q2labsolutions.com.

MAPs

Full Biomarker Menu
DiscoveryMAP® v. 3.3
ExplorerMAP™ v. 1.0
HumanMAP® v. 2.0
CardiovascularMAP® v. 3.0
AngiogenesisMAP® v. 1.0
InflammationMAP® v. 1.0
ImmunoMAP® v. 1.0
NeuroMAP™ v. 1.0
MetabolicMAP® v. 1.0
KidneyMAP®
CytokineMAP A
CytokineMAP B

RESOURCES

Bibliography
White Papers
Events
Webinars
Blog

SUPPORT

Customer Support
Speak to a Scientist
Assay Change Log
Request a Biomarker
FAQs

SOLUTIONS

Results Processing
Assay Development
Quality Control
Project Management

SERVICES

Multiplexed Assay Services
Ultrasensitive Assays
TruCulture

  • Jobs
  • Terms of Use
  • Privacy Practice
  • Analytes Listing
Copyright © 2023 Rules-Based Medicine. All rights reserved. RBM does not sell your personal information